期刊文献+

帕利哌酮缓释微丸的处方优化 被引量:2

Formulation Optimization of Paliperidone Sustained-release Pellets
原文传递
导出
摘要 该研究采用挤出滚圆法制备了帕利哌酮丸芯,再用甲基丙烯酸共聚物(Eudragit)包衣制备缓释微丸,并采用正交设计分别优化了载药丸芯和缓释微丸的处方包衣工艺参数。结果表明,采用Eudragit RS30D与Eudragit RL30D作为包衣材料,且Eudragit RS30D占包衣材料总量65%时得到的优化缓释微丸在不同pH介质中的体外释放行为符合一级动力学方程。 The paliperidone-loaded pill cores were prepared by the extrusion spheronization process,then the sustained-release pellets were obtained by coating with methacrylic acid copolymer(Eudragit)thin film.The formulation and process parameters of the pill cores and coated pellets were optimized by orthogonal design.The results showed that the in vitro release behavior of the optimal sustained-release pellets coated with the thin film consisted of Eudragit RS30D(which accounted for 65%of the total amount of coating materials)and Eudragit RL30D could be described by first-order kinetic equation.
作者 郑林 李黎 尹罡 廖蓉惠 邓盛齐 陶静 ZHENG Lin;LI Li;YIN Gang;LIAO Ronghui;DENG Shengqi;TAO Jing(Antibiotics Research and Re-evaluation Key Lab.of Sichuan Province,Sichuan Industrial Institute of Antibiotics,School of Pharmacy,Chengdu University,Chengdu 610052)
机构地区 成都大学药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2023年第2期224-229,共6页 Chinese Journal of Pharmaceuticals
基金 成都大学实验教学研究与改革项目(cdsyjg2022003)给予资助。
关键词 帕利哌酮 挤出滚圆法 流化床包衣 缓释微丸 体外释放 paliperidone extrusion spheronization fluidized bed coating sustained-release pellet release in vitro
  • 相关文献

参考文献3

二级参考文献40

  • 1Dhandapani NV, Shrestha A, Shrestha N, et al. Pelletization by extrusion-spheronization: A detailed review [J]. All Res J Biol, 2012, 3 (2) : 10-23.
  • 2Trivedi NR, Rajan MG, Johnson JR, et al. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process [J]. Crit Rev Ther Drug Carrier Syst, 2007, 24 (1): 1-40.
  • 3Pinto JF, Lameiro MH, Martins P. Investigation on the co- extrudability and spheronization properties of wet masses [J]. Int J Pharm, 2001,227 (1-2) : 71-80.
  • 4Litster J, Ennis BJ. The Science and Engineering of Granulation Processes [M]. Dordrecht: Kluwer Academic Publishers, 2004: 4-10.
  • 5Sinha VR, Agrawal MK, Agarwal A, et al. Extrusion- spheronization: process variables and characterization [J]. Crit Rev Ther Drug Carrier Syst, 2009, 26 (3) : 275-331.
  • 6Bhaskaran S, Lakshmi PK. Extrusion spheronization-a review [J]. IntJPharmTeeh Res, 2012, 2 (4) : 2429-2433.
  • 7Otero-Espinar F J, Luzardo-Alvarez A, Blanco-M6ndez J. Non-MCC materials as extrusion-spheronization aids in pellets production[J]. J Drug Del Sei Teehl, 2010, 20 (4) : 303-318.
  • 8Duki6-Ott A, Thommes M, Remon JP, et al. Production ofpellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review [J]. Eur J Pharm Biopharm, 2009, 71 (1) : 38-46.
  • 9Alanazi FK, Sakr WF, Sakr AA. Impact of HPMC optimization on rheological behavior of microcrystalline cellulose during wet granulation [J]. Int JPharm Pharm Sci, 2011, 3 (3) : 262-269.
  • 10Robinson WS, Barker J. Opportunities for mixer torque rheometry [C]//The 14th international processing packaging technology event for Asia. Propak Asia. Bangkok: 2006.

共引文献10

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部